Verona Pharma Announces US FDA Approval of Ohtuvayre™ …
Jun 26, 2024 · Verona has evaluated nebulized Ohtuvayre in its Phase 3 clinical program ENHANCE (“Ensifentrine as a Novel inHAled Nebulized COPD thErapy”) for COPD …
Verona Pharma Press Releases & Updates
Jan 7, 2025 · Follow Verona Pharma’s latest updates through our press releases. Stay informed on financial results, strategic financing, clinical developments, and upcoming presentations as …
Verona Pharma to Present Six Analyses of the Phase 3 ENHANCE …
Sep 30, 2024 · Verona has evaluated nebulized Ohtuvayre in its Phase 3 clinical program ENHANCE (“Ensifentrine as a Novel inHAled Nebulized COPD thErapy”) for COPD …
Verona Pharma Announces the US FDA has Accepted the New …
Sep 11, 2023 · Ensifentrine, if approved, is expected to be the first novel mechanism available for the maintenance treatment of COPD in more than 10 years. We believe its bronchodilator and …
Verona cuts $400m loan deal as it preps COPD drug for market
3 days ago · Verona Pharma has agreed a new $400 million debt facility with Oxford Finance and Hercules Capital designed to help the company navigate the possible approval and launch of …
Verona’s first-in-class COPD drug ‘could transform market’
5 days ago · Verona Pharma has claimed FDA approval for its chronic obstructive pulmonary disease (COPD) drug ensifentrine, which has been tipped as a future blockbuster.
Verona prepares for US launch of ensifentrine for COPD
May 29, 2024 · Verona intends to submit an investigational new drug application to the FDA to initiate a Phase II clinical trial assessing the efficacy and safety of a fixed-dose combination …
US FDA Approves Verona Pharma's Inhaled COPD Therapy - U.S. News …
Jun 26, 2024 · (Reuters) -The U.S. Food and Drug Administration has granted approval to a treatment from Verona Pharma for a chronic lung disease that commonly affects smokers, the …
Verona says COPD drug is off to a flying start | pharmaphorum
Jan 7, 2025 · Verona Pharma has blockbuster hopes for its recently approved drug for chronic obstructive pulmonary disorder (COPD), and preliminary sales figures for the drug suggest it is …
Verona Pharma Stock Catapulted 19% Over Four Days — Here's …
Jan 16, 2025 · Verona Pharma (VRNA) stock hit a record high Thursday — running up 19% over the past four days — on continued enthusiasm for its COPD treatment, Ohtuvayre. Ohtuvayre …